Camlin Fine Sciences Ltd — Regulatory Filings 2021

Jan 29, 2021

==> picture [100 x 31] intentionally omitted <==

29[th] January, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Notice of the Meeting of Board of Directors for considering and approving the Un‐audited Financial Results for the quarter ended 31[ST] December, 2020.

Dear Sir/Madam,

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 8[th] February, 2021 to, inter‐alia consider, take on record and approve the standalone and consolidated un‐audited financial results for the third quarter ended 31[st] December, 2020.

As informed by the Company, vide intimation dated 2[nd] January, 2021, the trading window of the Company for dealing in the equity shares has been closed from 1[st] January, 2021 and shall re‐open 48 hours after the declaration of financial results for the quarter ended 31[st] December, 2020.

Kindly take the above information on records.

Thanking You, For Camlin Fine Sciences Limited Mr. Mandar Godbole GM Legal, Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==